Quetiapine Fumarate Oral Tablets (Immediate-Release) Suppliers & Bulk Manufacturers

Available Forms: Oral tablets (Immediate-Release)

Available Strengths: 25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg

Reference Brands: US: Seroquel®, Seroquel XR®; EU: Seroquel®, Seroquel Prolong®, Quetiapine Teva®

Category: Antipsychotropic Drugs

Quetiapine Fumarate Oral tablets (Immediate-Release) is available in Oral tablets (Immediate-Release) and strengths such as 25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Quetiapine Fumarate Oral tablets (Immediate-Release) is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Quetiapine Fumarate Oral tablets (Immediate-Release) can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Quetiapine Fumarate Immediate-Release tablets are FDA-approved in the USA for treating schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder. As an atypical antipsychotic, it carries a Boxed Warning regarding increased risk of suicidal thoughts and elderly dementia-related psychosis. Manufacturers must adhere to GMP standards, accurate labeling, and post-marketing surveillance. In the European Union, it is authorized through national or mutual recognition procedures, with obligations for Risk Management Plans (RMPs), Periodic Safety Update Reports (PSURs), and bioequivalence for generics. Discover dossier-complete Quetiapine IR tablets at Pharmatradz.com for global B2B sourcing.